Improving imaging techniques for cancer treatment using advanced technology
High Energy and Spatial Resolution Multi-Isotope SPECT Imaging of Targeted Alpha-Emitters and their Daughters
This study is working on a new imaging system that helps doctors see how well certain cancer treatments are working by providing clearer pictures, which could lead to better treatment plans and outcomes for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11171753 on NIH RePORTER |
What this research studies
This research focuses on enhancing single photon emission computed tomography (SPECT) imaging to better visualize and assess the effectiveness of targeted alpha-emitters in cancer therapy. By developing a new SPECT system that significantly improves energy and spatial resolution, the research aims to allow for more accurate imaging of various radionuclides used in medical treatments. This advanced imaging technology will enable clinicians to obtain quantitative data and visualize multiple radionuclides simultaneously, which is crucial for the success of modern radiopharmaceutical therapies. Patients may benefit from more precise imaging that can lead to better treatment planning and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing treatment with radiopharmaceutical therapies that utilize alpha-particle emitters.
Not a fit: Patients not undergoing radiopharmaceutical therapy or those with conditions unrelated to cancer may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments through improved imaging techniques that allow for better monitoring of therapy.
How similar studies have performed: Previous research has shown success in enhancing imaging techniques for cancer therapies, making this approach promising yet innovative.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Sgouros, George — Johns Hopkins University
- Study coordinator: Sgouros, George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.